Toward therapeutic trials in primary lateral sclerosis

Area of Science:

• Neuroscience
• Neurology
• Rare Diseases

Background:

• Primary lateral sclerosis (PLS) is a rare neurodegenerative disorder affecting upper motor neurons.
• PLS causes progressive physical and communication disability, typically with slow evolution.
• Unlike amyotrophic lateral sclerosis (ALS), PLS is not typically associated with reduced life expectancy.

Purpose of the Study:

• To review recent advances and ongoing initiatives for Primary Lateral Sclerosis (PLS) clinical trial readiness.
• To highlight efforts crucial for developing the first therapeutic trials for PLS patients.

Main Methods:

• Review of current clinical research efforts in PLS.
• Examination of initiatives including patient registries, biorepositories, and natural history studies.
• Assessment of outcome measure validation and biomarker development strategies.

Main Results:

• Significant progress is being made in preparing for clinical trials in PLS.
• International collaborative efforts are essential for advancing PLS research.
• Key initiatives include establishing patient registries, conducting natural history studies, and validating outcome measures.

Conclusions:

• Ongoing research is critical for overcoming challenges in PLS drug development.
• Advances in patient data collection and biomarker research are paving the way for therapeutic trials.
• Collaborative international efforts are vital for accelerating the development of treatments for PLS.